En esta página
PEPG PepGen Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 6, 2026
$2,28
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$1,31mínimo 52 semanas
$7,80máximo 52 semanas
Capitalización Bursátil
$157M
P/E
-1.1
BPA
$-2.12
tus insignias
Rango 52S
$1–$8
Calificación del Analista
STRONG BUY
Precio Objetivo
$10
P/E
-1.1
ROE
-82.0%
Margen de Beneficio Neto
·
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
PEPG Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$2.28
Capitalización Bursátil
$157M
P/E
-1.1
BPA
$-2.12
ROE
-82.0%
Rango 52S
$1–$8
PEPG Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
BPA$-2.122021-12-31 → 2025-12-31
Flujo de caja libre$-82M2022-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | PEPG | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -1.1promedio 5A ≈-2.4 | ≈-2.4 | · | · | |
| P/B (P/C) | 1.1promedio 5A ≈1.8 | ≈1.8 | 3.4 | Valor razonable | |
| Price / FCF (Precio / FCF) | -1.9promedio 5A ≈-3.6 | ≈-3.6 | · | · | |
| Price / Cash Flow (Precio / Flujo de Caja) | -1.9promedio 5A ≈-3.7 | ≈-3.7 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 1.1promedio 5A ≈1.8 | ≈1.8 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | PEPG | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| ROA | -55.2%promedio 5A ≈-49.6% | ≈-49.6% | -55.2% | En línea | |
| ROE | -82.0%promedio 5A ≈-64.1% | ≈-64.1% | -47.5% | Débil | |
| ROIC | -63.5%promedio 5A ≈-65.9% | ≈-65.9% | -42.5% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | PEPG | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 13.4promedio 5A ≈8.9 | ≈8.9 | 8.1 | Liquidez sólida | |
| Quick Ratio (Ratio Rápido) | 11.7promedio 5A ≈8.7 | ≈8.7 | 6.1 | Liquidez sólida |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
10.2%
Próximo informe
Nov 10, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 5, 2026 | $-0.26 | $-0.30 | 12.1% |
| 31 de marzo de 2026 | May 6, 2026 | $-0.26 | $-0.32 | 18.3% |
| 31 de diciembre de 2025 | $-0.27 | $-0.38 | 29.3% | |
| 30 de septiembre de 2025 | $-0.52 | $-0.58 | 9.8% | |
| 30 de junio de 2025 | $-0.70 | $-0.84 | 17.1% | |
| 31 de marzo de 2025 | $-0.92 | $-0.73 | -25.3% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| R&D Expense | $71M | $76M | $68M | $54M | $19M | |
| SG&A Expense | $23M | $21M | $17M | $14M | $8M | |
| Operating Expenses | $94M | $98M | $85M | $68M | $27M | |
| Operating Income | $-94M | $-98M | $-85M | $-68M | $-27M | |
| Interest Income | $4M | $7M | $6M | $3M | · | |
| Other Non-op | $-11.0K | $-1.0K | $-187.0K | $110.0K | $-172.0K | |
| Pretax Income | $-90M | $-91M | $-79M | $-65M | $-27M | |
| Income Tax | $49.0K | $-617.0K | $73.0K | $4M | $0 | |
| Net Income | $-90M | $-90M | $-79M | $-69M | $-27M | |
| EPS (Basic) | $-2.12 | $-2.85 | $-3.30 | $-4.42 | $-30.27 | |
| EPS (Diluted) | $-2.12 | $-2.85 | $-3.30 | $-4.42 | $-30.27 | |
| Shares (Basic) | 42,221,808 | 31,583,073 | 23,796,000 | 15,639,728 | 901,108 | |
| Shares (Diluted) | 42,221,808 | 31,583,073 | 23,796,000 | 15,639,728 | 901,108 | |
| EBITDA | $-92M | $-96M | $-84M | $-68M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $61M | $49M | $81M | $182M | $133M | |
| Short-term Investments | $88M | $71M | $30M | $0 | · | |
| Prepaid Expense | $3M | $4M | $2M | $4M | $2M | |
| Current Assets | $151M | $124M | $113M | $186M | $140M | |
| PP&E (Net) | $2M | $4M | $5M | $3M | $636.0K | |
| PP&E (Gross) | $6M | $7M | $6M | $4M | $1M | |
| Accum. Depreciation | $4M | $3M | $2M | $389.0K | $430.0K | |
| Other Non-current Assets | $372.0K | $426.0K | $442.0K | $1M | $3M | |
| Total Assets | $174M | $151M | $143M | $217M | $144M | |
| Accounts Payable | $822.0K | $2M | $1M | $1M | $3M | |
| Accrued Liabilities | $9M | $12M | $14M | $12M | $7M | |
| Current Liabilities | $13M | $17M | $18M | $19M | $10M | |
| Capital Leases | $14M | $16M | $17M | $19M | · | |
| Total Liabilities | $26M | $32M | $35M | $38M | $11M | |
| Common Stock | $7.0K | $3.0K | $2.0K | $2.0K | · | |
| Retained Earnings | $-361M | $-271M | $-181M | $-103M | $-34M | |
| AOCI | $11.0K | $23.0K | $34.0K | $-81.0K | $17.0K | |
| Stockholders' Equity | $147M | $119M | $108M | $180M | $-32M | |
| Liabilities + Equity | $174M | $151M | $143M | $217M | $144M | |
| Shares Outstanding | 68,874,944 | 32,619,663 | 23,823,241 | 23,713,196 | 963,588 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| D&A | $1M | $2M | $1M | $500.0K | $200.0K | |
| Stock-based Comp | $11M | $11M | $7M | $5M | $2M | |
| Other Non-cash | $-4M | $-5M | $1M | $5M | · | |
| Operating Cash Flow | $-82M | $-82M | $-69M | $-59M | $-23M | |
| CapEx | $264.0K | $497.0K | $3M | $4M | $500.0K | |
| Investing Cash Flow | $-15M | $-38M | $-32M | $-4M | $-500.0K | |
| Stock Issued | · | $10M | · | $114M | · | |
| Net Stock Activity | · | $10M | · | $114M | · | |
| Financing Cash Flow | $108M | $89M | $-189.0K | $112M | $148M | |
| Net Change in Cash | $11M | $-31M | $-101M | $49M | $125M | |
| Taxes Paid | $82.0K | $71.0K | $3M | · | · | |
| Free Cash Flow | $-82M | $-83M | $-72M | $-63M | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| ROA | -55.2% | -61.2% | -43.6% | -38.3% | · | |
| ROE | -82.0% | -70.3% | -67.1% | -37.1% | · | |
| ROIC | -63.5% | -81.8% | -78.2% | -40.2% | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 11.9 | 7.4 | 6.4 | 9.9 | · | |
| Quick Ratio | 11.7 | 7.2 | 6.3 | 9.7 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Book Value / Share | $2.14 | $3.64 | $4.55 | $7.58 | · | |
| Cash Flow / Share | $-1.93 | $-2.61 | $-2.90 | $-3.79 | · | |
| Cash / Share | $0.88 | $1.52 | $3.39 | $7.66 | · | |
| EPS (TTM) | $-2.12 | $-2.85 | $-3.30 | $-4.42 | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Net Income TTM | $-90M | $-90M | $-79M | $-69M | · | |
| Market Cap | $448M | $124M | $162M | $317M | · | |
| P/E | -3.1 | -1.3 | -2.1 | -3.0 | · | |
| P/B | 3.0 | 1.0 | 1.5 | 1.8 | · | |
| P / Tangible Book | 3.0 | 1.0 | 1.5 | 1.8 | · | |
| P / Cash Flow | -5.5 | -1.5 | -2.3 | -5.3 | · | |
| P / FCF | -5.5 | -1.5 | -2.3 | -5.0 | · | |
| Earnings Yield | -32.6% | -75.2% | -48.5% | -33.1% | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $13M | $13M | $14M | $13M | $18M | $25M | $19M | $18M | $25M | $15M | $16M | $21M | $17M | $14M | $16M | $14M | |
| SG&A Expense | $6M | $6M | $6M | $5M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $3M | |
| Operating Expenses | $19M | $19M | $20M | $19M | $24M | $31M | $24M | $23M | $30M | $20M | $21M | $25M | $21M | $18M | $20M | $18M | |
| Operating Income | $-19M | $-19M | $-20M | $-19M | $-24M | $-31M | $-24M | $-23M | $-30M | $-20M | $-21M | $-25M | $-21M | $-18M | $-20M | $-18M | |
| Interest Income | $1M | $1M | $1M | $634.0K | $842.0K | $1M | $1M | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $943.0K | $250.0K | |
| Other Non-op | $50.0K | $-56.0K | $-5.0K | $-6.0K | $3.0K | $-3.0K | $26.0K | $-39.0K | $-31.0K | $43.0K | $43.0K | $-88.0K | $-62.0K | $-80.0K | $4.0K | $76.0K | |
| Pretax Income | $-18M | $-18M | $-18M | $-18M | $-23M | $-30M | $-23M | $-21M | $-28M | $-18M | $-19M | $-23M | $-20M | $-16M | $-19M | $-17M | |
| Income Tax | $16.0K | $15.0K | $49.0K | $0 | $0 | $0 | $-617.0K | $0 | $0 | · | · | · | · | · | · | · | |
| Net Income | $-18M | $-18M | $-18M | $-18M | $-23M | $-30M | $-22M | $-21M | $-28M | $-18M | $-19M | $-23M | $-20M | $-16M | $-19M | $-17M | |
| EPS (Basic) | $-0.26 | $-0.26 | $0.02 | $-0.52 | $-0.70 | $-0.92 | $-0.69 | $-0.66 | $-0.87 | $-0.63 | $-0.81 | $-0.98 | $-0.82 | $-0.69 | $-0.79 | $-1.23 | |
| EPS (Diluted) | $-0.26 | $-0.26 | $0.02 | $-0.52 | $-0.70 | $-0.92 | $-0.69 | $-0.66 | $-0.87 | $-0.63 | $-0.81 | $-0.98 | $-0.82 | $-0.69 | $-0.79 | $-1.23 | |
| Shares (Basic) | 69,202,376 | 69,091,100 | · | 34,362,876 | 32,748,646 | 32,674,720 | · | 32,581,542 | 32,469,187 | 28,656,401 | · | 23,790,430 | 23,790,430 | 23,761,915 | 23,562,395 | 14,090,455 | |
| Shares (Diluted) | 69,202,376 | 69,091,100 | · | 34,362,876 | 32,748,646 | 32,674,720 | · | 32,581,542 | 32,469,187 | 28,656,401 | · | 23,790,430 | 23,790,430 | 23,761,915 | 23,562,395 | 14,090,455 | |
| EBITDA | $-19M | $-19M | · | $-18M | $-24M | $-31M | · | $-23M | $-30M | $-19M | · | $-24M | $-21M | $-18M | $-19M | $-18M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $23M | $42M | $61M | $143M | $35M | $44M | $49M | $42M | $66M | $134M | $81M | $130M | $147M | $165M | $196M | $219M | |
| Short-term Investments | $94M | $90M | $88M | $21M | $40M | $54M | $71M | $97M | $95M | $41M | $30M | · | · | · | · | · | |
| Prepaid Expense | $3M | $2M | $3M | $3M | $3M | $3M | $4M | $4M | $3M | $2M | $2M | $4M | $3M | $3M | $5M | $3M | |
| Current Assets | $120M | $134M | $151M | $166M | $77M | $101M | $124M | $142M | $165M | $178M | $113M | $133M | $150M | $168M | $204M | $226M | |
| PP&E (Net) | $1M | $2M | $2M | $2M | $2M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $3M | $3M | |
| PP&E (Gross) | $6M | $6M | $6M | $6M | $6M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | $3M | $3M | |
| Accum. Depreciation | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $871.0K | $540.0K | $245.0K | $415.0K | |
| Other Non-current Assets | $265.0K | $389.0K | $372.0K | $372.0K | $426.0K | $426.0K | $426.0K | $426.0K | $2M | $2M | $442.0K | $2M | $2M | $1M | $1M | $1M | |
| Total Assets | $141M | $156M | $174M | $190M | $102M | $127M | $151M | $170M | $194M | $207M | $143M | $164M | $182M | $201M | $208M | $231M | |
| Accounts Payable | $1M | $622.0K | $822.0K | $766.0K | $856.0K | $3M | $2M | $6M | $8M | $1M | $1M | $4M | $2M | $1M | $5M | $5M | |
| Accrued Liabilities | $5M | $5M | $9M | $9M | $12M | $15M | $12M | $8M | $11M | $7M | $14M | $14M | $12M | $13M | $11M | $15M | |
| Current Liabilities | $9M | $9M | $13M | $13M | $16M | $20M | $17M | $17M | $22M | $11M | $18M | $21M | $17M | $18M | $16M | $21M | |
| Capital Leases | $13M | $13M | $14M | $14M | $15M | $15M | $16M | $16M | $16M | $17M | $17M | $17M | $18M | $18M | · | · | |
| Total Liabilities | $22M | $22M | $26M | $27M | $31M | $36M | $32M | $33M | $38M | $28M | $35M | $38M | $35M | $36M | $16M | $21M | |
| Common Stock | $7.0K | $7.0K | $7.0K | $7.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | |
| Retained Earnings | $-397M | $-379M | $-361M | $-343M | $-325M | $-302M | $-271M | $-249M | $-228M | $-200M | $-181M | $-162M | $-139M | $-119M | $-88M | $-69M | |
| AOCI | $-117.0K | $-59.0K | $11.0K | $-25.0K | $-43.0K | $-22.0K | $23.0K | $91.0K | $-75.0K | $-37.0K | $34.0K | $-57.0K | $13.0K | $-28.0K | $-130.0K | $-99.0K | |
| Stockholders' Equity | $120M | $134M | $147M | $163M | $71M | $92M | $119M | $137M | $155M | $179M | $108M | $126M | $147M | $165M | $193M | $210M | |
| Liabilities + Equity | $141M | $156M | $174M | $190M | $102M | $127M | $151M | $170M | $194M | $207M | $143M | $164M | $182M | $201M | $208M | $231M | |
| Shares Outstanding | · | · | 68,874,944 | · | · | · | 32,619,663 | · | · | · | 23,823,241 | · | · | · | · | · |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $300.0K | $300.0K | $400.0K | $300.0K | $300.0K | $400.0K | $300.0K | $400.0K | $400.0K | $400.0K | $400.0K | $300.0K | $300.0K | $200.0K | $100.0K | $100.0K | |
| Stock-based Comp | $3M | $3M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | |
| Other Non-cash | · | $-4M | · | · | · | $3M | · | · | · | $-7M | · | · | · | $-651.0K | · | · | |
| Operating Cash Flow | $-16M | $-18M | $-16M | $-19M | $-24M | $-23M | $-19M | $-24M | $-16M | $-23M | $-19M | $-16M | $-17M | $-15M | $-21M | $-13M | |
| CapEx | $30.0K | $0 | $-1.0K | $97.0K | $43.0K | $125.0K | $228.0K | $185.0K | $31.0K | $53.0K | $184.0K | $225.0K | $1M | $1M | $430.0K | $609.0K | |
| Investing Cash Flow | $-4M | $-1M | $-66M | $19M | $15M | $17M | $27M | $-133.0K | $-53M | $-11M | $-30M | $-225.0K | $-1M | $-1M | $-430.0K | $-609.0K | |
| Stock Issued | $0 | $2M | · | $0 | $0 | $0 | $0 | $0 | $0 | $10M | · | · | · | · | $0 | · | |
| Net Stock Activity | · | $2M | · | · | · | $0 | · | · | · | $10M | · | · | · | · | · | · | |
| Financing Cash Flow | $-65.0K | $2M | $-171.0K | $108M | $98.0K | $0 | $128.0K | $327.0K | $1M | $87M | $26.0K | $-534.0K | $-19.0K | $130.0K | $-1M | $113M | |
| Net Change in Cash | $-19M | $-18M | $-82M | $108M | $-9M | $-6M | $7M | $-24M | $-68M | $53M | $-49M | $-17M | $-18M | $-16M | $-23M | $100M | |
| Taxes Paid | $49.0K | $0 | $-4.0K | $0 | $0 | $86.0K | $0 | $0 | $71.0K | $0 | · | · | · | · | · | · | |
| Free Cash Flow | · | $-18M | · | · | · | $-23M | · | · | · | $-23M | · | · | · | $-17M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -14.6% | -12.5% | · | -10.0% | -15.6% | -18.1% | · | -12.8% | -15.1% | -8.8% | · | -12.5% | -9.5% | -9.8% | -17.8% | -15.0% | |
| ROE | -18.7% | -15.7% | · | -12.0% | -20.4% | -22.3% | · | -16.2% | -18.7% | -10.5% | · | -14.6% | -10.9% | -28.3% | -19.3% | -16.5% | |
| ROIC | -15.9% | -14.1% | · | -11.4% | -33.6% | · | · | · | · | · | · | · | · | · | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 13.4 | 15.0 | · | 13.1 | 4.7 | 4.9 | · | 8.5 | 7.5 | 15.8 | · | 6.4 | 8.9 | 9.3 | 13.2 | 11.0 | |
| Quick Ratio | 13.0 | 14.8 | · | 12.9 | 4.6 | 4.8 | · | 8.3 | 7.3 | 15.6 | · | 6.2 | 8.7 | 9.2 | 12.6 | 10.6 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow / Share | · | $-0.27 | · | · | · | $-0.70 | · | · | · | $-0.79 | · | · | · | $-0.65 | · | · | |
| EPS (TTM) | $-1.02 | $-1.46 | · | $-2.83 | $-2.97 | $-3.14 | · | $-2.97 | $-3.29 | $-3.24 | · | · | · | · | $-28.71 | $-36.99 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-72M | $-77M | · | $-94M | $-97M | $-102M | · | $-87M | $-89M | $-80M | · | · | · | · | $-61M | $-51M | |
| P/E | -1.8 | -1.2 | · | -1.6 | -0.4 | -0.4 | · | -2.9 | -4.9 | -4.5 | · | · | · | · | -0.3 | -0.3 | |
| Earnings Yield | -56.7% | -82.5% | · | -61.3% | -267.6% | -223.5% | · | -34.7% | -20.6% | -22.0% | · | · | · | · | -316.2% | -372.5% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Beneficio neto | $-90M | $-90M | $-79M | $-69M | $-27M |
| EPS Diluido | $-2.12 | $-2.85 | $-3.30 | $-4.42 | $-30.27 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 11.9 | 7.4 | 6.4 | 9.9 | · |
| Ratio Rápido | 11.7 | 7.2 | 6.3 | 9.7 | · |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-82M | $-83M | $-72M | $-63M | · |
Propietarios institucionales (13F) 79 declarantes · $107.0M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
79
Valor en tenencia
$107.0M
Nuevas posiciones
6
Posiciones cerradas
28
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 6 (-25 vs trimestre anterior) | 28 (+10 vs trimestre anterior) | 21 (-8 vs trimestre anterior) | 28 (+1 vs trimestre anterior) | -4.9M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $36 116 181 | 20 064 545 | 33,77% | Acciones |
| VANGUARD GROUP INC | $14 405 549 | 2 212 834 | 13,47% | Acciones |
| Commodore Capital LP | $8 055 000 | 4 475 000 | 7,53% | Acciones |
| VIKING GLOBAL INVESTORS LP | $6 268 381 | 3 482 434 | 5,86% | Acciones |
| Laurion Capital Management LP | $4 951 539 | 2 750 855 | 4,63% | Acciones |
| ADAR1 Capital Management, LLC | $4 663 953 | 2 591 085 | 4,36% | Acciones |
| Vivo Capital, LLC | $4 185 000 | 2 325 000 | 3,91% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $3 484 656 | 1 935 920 | 3,26% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $3 216 177 | 1 786 765 | 3,01% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $2 736 443 | 1 520 246 | 2,56% | Acciones |
| BlackRock, Inc. | $2 347 672 | 1 304 262 | 2,20% | Acciones |
| MARSHALL WACE, LLP | $1 560 585 | 866 992 | 1,46% | Acciones |
| CITADEL ADVISORS LLC | $1 185 086 | 658 381 | 1,11% | Acciones |
| AWM Investment Company, Inc. | $1 080 000 | 600 000 | 1,01% | Acciones |
| MONIMUS CAPITAL MANAGEMENT, LP | $1 057 838 | 587 688 | 0,99% | Acciones |
| Squarepoint Ops LLC | $952 349 | 529 083 | 0,89% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $942 806 | 523 473 | 0,88% | Acciones |
| Creek Drive Management Group LLC | $810 000 | 450 000 | 0,76% | Acciones |
| Ikarian Capital, LLC | $804 897 | 447 165 | 0,75% | Acciones |
| DIADEMA PARTNERS LP | $671 911 | 373 284 | 0,63% | Acciones |
| BOOTHBAY FUND MANAGEMENT, LLC | $659 054 | 366 141 | 0,62% | Acciones |
| Rosalind Advisors, Inc. | $630 000 | 350 000 | 0,59% | Acciones |
| Driehaus Capital Management LLC | $503 836 | 279 909 | 0,47% | Acciones |
| Boxer Capital Management, LLC | $491 206 | 272 892 | 0,46% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $470 657 | 261 476 | 0,44% | Acciones |
| XTX Topco Ltd | $441 625 | 245 347 | 0,41% | Acciones |
| STATE STREET CORP | $412 902 | 229 390 | 0,39% | Acciones |
| Artia Global Partners LP | $369 583 | 205 324 | 0,35% | Acciones |
| JANE STREET GROUP, LLC | $310 342 | 172 412 | 0,29% | Acciones |
| GOLDMAN SACHS GROUP INC | $302 598 | 168 110 | 0,28% | Acciones |
| Connor, Clark & Lunn Investment Management Ltd. | $201 728 | 112 071 | 0,19% | Acciones |
| UBS Group AG | $199 211 | 110 673 | 0,19% | Acciones |
| NORTHERN TRUST CORP | $177 728 | 98 738 | 0,17% | Acciones |
| Qube Research & Technologies Ltd | $177 446 | 98 581 | 0,17% | Acciones |
| RBF Capital, LLC | $171 076 | 95 042 | 0,16% | Acciones |
| Persistent Asset Partners Ltd | $171 005 | 95 003 | 0,16% | Acciones |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $168 660 | 93 700 | 0,16% | Acciones |
| Cubist Systematic Strategies, LLC | $141 695 | 30 670 | 0,13% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $135 749 | 75 416 | 0,13% | Acciones |
| TWO SIGMA ADVISERS, LP | $135 447 | 20 806 | 0,13% | Acciones |
| Rangeley Capital, LLC | $126 000 | 70 000 | 0,12% | Acciones |
| Verdad Advisers, LP | $120 384 | 66 880 | 0,11% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $119 282 | 66 268 | 0,11% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $97 319 | 54 113 | 0,09% | Acciones |
| MORGAN STANLEY | $87 916 | 48 842 | 0,08% | Acciones |
| AMERICAN CENTURY COMPANIES INC | $76 682 | 42 601 | 0,07% | Acciones |
| Quadrature Capital Ltd | $73 685 | 40 936 | 0,07% | Acciones |
| Point72 Asset Management, L.P. | $71 496 | 39 720 | 0,07% | Acciones |
| Rathbones Group PLC | $57 605 | 32 003 | 0,05% | Acciones |
| READYSTATE ASSET MANAGEMENT LP | $51 082 | 28 379 | 0,05% | Acciones |
Activistas y propietarios del %+ 5 1 tenencia
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×5 presentaciones | 30 de septiembre de 2025 | 29,20% | Enmienda | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 19 insiders · 10 directivos · 9 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| James G Mcarthur | President and CEO | 4 de marzo de 2026 S | 296 326 | 0 | 2 | $-32 875 |
| Noel Donnelly | Chief Financial Officer | 4 de marzo de 2026 S | 111 603 | 0 | 2 | $-12 988 |
| Kasra Kasraian | Chief Technical Officer | 21 de mayo de 2026 S | 50 074 | 0 | 1 | $-1 739 |
| Paul Streck | EVP, Head of R&D | 4 de marzo de 2026 S | 76 226 | 0 | 2 | $-11 709 |
| Joseph Vittiglio | Chief Business & Legal Officer | 1 de marzo de 2026 A | 65 717 | 0 | 0 | $0 |
| Mary Beth Delena | General Counsel | 3 de marzo de 2025 A | 14 968 | 0 | 0 | $0 |
| Michelle L Mellion | Chief Medical Officer | 25 de julio de 2024 M | 0 | 0 | 0 | $0 |
| Niels Svenstrup | SVP, Chem. Mfg & Controls | 17 de mayo de 2024 S | 0 | 0 | 0 | $0 |
| Jaya Goyal | EVP, Res. & Preclin. Dev. | 24 de marzo de 2023 M | 0 | 0 | 0 | $0 |
| Sonia Bracegirdle | Sr. VP Strategy & Operations | 6 de mayo de 2022 A | · | 0 | 0 | $0 |
| Lisa Wyman | Consejero | 18 de junio de 2026 A | · | 0 | 0 | $0 |
| Howard Mayer | Consejero | 18 de junio de 2026 A | · | 0 | 0 | $0 |
| Joshua Resnick | Consejero | 18 de junio de 2026 A | · | 0 | 0 | $0 |
| Habib J Dable | Consejero | 18 de junio de 2026 A | · | 0 | 0 | $0 |
| Laurie Keating | Consejero | 18 de junio de 2026 A | 4 166 | 0 | 0 | $0 |
| Mitchell H. Finer | Consejero | 18 de junio de 2026 A | · | 0 | 0 | $0 |
| Heidi Henson | Consejero | 18 de junio de 2026 A | · | 0 | 0 | $0 |
| Christopher Ashton | Consejero | 20 de junio de 2024 A | · | 0 | 0 | $0 |
| Oxford Sciences Innovation plc | · | 30 de septiembre de 2025 P | 4 955 388 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 6 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| IBRN · iShares Trust | 0,19% | 4 634 SH | 11 de septiembre de 2026 | Diario |
| IWC · iShares Trust | 0,03% | 139 850 SH | 11 de septiembre de 2026 | Diario |
| IBB · iShares Trust | 0,01% | 477 680 SH | 11 de septiembre de 2026 | Diario |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,01% | 4 899 SH | 2 de octubre de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 480 909 SH | 19 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 408 449 SH | 19 de agosto de 2026 | Diario |
PEPG Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 14 analistas
COMPRA
Objetivo mediano
$10.50
+360,5%
7 50,0%
Compra fuerte
5 35,7%
Compra
1 7,1%
Mantener
1 7,1%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
8 analistas · 2026-09-30Objetivo medio $10.19 +346,8%
← Por Debajo de Todos los Objetivos
Precio Actual $2.28
Mín$2.50
Media$10.19
Máx$20.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| PEPG | $448M | -3.1 | · | · | -82.0% | · |
| ALXO | $61M | -0.6 | · | · | -225.0% | · |
| ORGO | $658M | 34.5 | 17.0% | 6.6% | 13.9% | · |
| AVXL | · | -16.5 | -36.1% | -991.4% | · | · |
| VYGR | $232M | -1.9 | -49.5% | -296.5% | -54.4% | · |
| TARA | $286M | -4.0 | · | · | -33.7% | · |
| NERV | $174M | -0.1 | · | · | 339.5% | · |
| CMPX | $958M | · | · | · | -45.9% | · |
| NBP | $1.06B | -19.0 | · | · | -21.4% | · |
| TNXP | $200M | -1.1 | 29.8% | -946.2% | -60.0% | · |
| ABOS | $128M | -1.1 | · | · | -129.4% | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 6, 2026